Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer.

EJNMMI Res · 2014 · PMC4884046 · PMID 26055936

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

89 Zr-bevacizumab PET may be used as an imaging agent, as tracer uptake showed a trend towards a positive correlation with PFS and OS.

also in 53,322 other papers

a positive trendno p-value reported

A positive trend but no significant correlation could be found between SUV peak and OS or PFS.

also in 11,005 other papers

did not reach statistical significanceno p-value reported

As shown in Figure 4 , correlations between tumor SUV peak and outcome parameters showed a positive trend, but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.